Statistical Considerations for NonInferiority/Equivalence Trials in Vaccine Development

Author： Wang W. W. B.   Mehrotra D. V.   Chan I. S. F.   Heyse J. F.  

Publisher： Taylor & Francis Ltd

ISSN： 1054-3406

Source： Journal of Biopharmaceutical Statistics, Vol.16, Iss.4, 2006-07, pp. : 429-441

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Design of Vaccine Equivalence/Non-Inferiority Trials with Correlated Multiple Binomial Endpoints

By Kong L.  

Journal of Biopharmaceutical Statistics, Vol. 16, Iss. 4, 2006-07 ,pp. : 555-572

Taylor & Francis Ltd

Access to resources Recommend Favorite

The Utility of Active-Controlled Noninferiority/Equivalence Trials in Drug Development

By Tsong Yi  

International Journal of Pharmaceutical Medicine, Vol. 21, Iss. 3, 2007-01 ,pp. : 225-233

Adis International

Access to resources Recommend Favorite

Understanding Non‐Inferiority Trials – A Different Type of Evidence

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 41, Iss. 1, 2011-03 ,pp. : 16-17

John Wiley & Sons Inc

Access to resources Recommend Favorite

Vaccine Clinical Trials – A Statistical Primer

By Mehrotra D. V.  

Journal of Biopharmaceutical Statistics, Vol. 16, Iss. 4, 2006-07 ,pp. : 403-414

Taylor & Francis Ltd

Access to resources Recommend Favorite

A Ratio Test in Active Control Non-Inferiority Trials with a Time-to-Event Endpoint

By Wang Yong-Cheng  

Journal of Biopharmaceutical Statistics, Vol. 16, Iss. 2, 2006-03 ,pp. : 151-164

Taylor & Francis Ltd

Access to resources Recommend Favorite